Patheon Pharmaceuticals India Private Limited
Founded: 2006
Status: Strike Off
Designation: Nominee Director
Milind Arunkumar Antani, Nominee Director and Director, with 23 companies.
Milind Arunkumar Antani has 19 years in corporate governance. Holds Nominee Director and Director roles. Currently with 11 companies, including Patheon Pharmaceuticals India Private Limited and Snd Pharma Research & Development Private Limited. Formerly with 12 companies, such as Biogen Idec Biotech India Private Limited and Actelion Pharmaceuticals India Private Limited. Engaged in General Business, Technology and more.
Founded: 2006
Status: Strike Off
Designation: Nominee Director
Founded: 2009
Status: Strike Off
Designation: Director
Founded: 2006
Status: Strike Off
Designation: Nominee Director
Founded: 2010
Status: Active
Designation: Director
Founded: 2004
Status: Active
Designation: Director
Founded: 2006
Status: Strike Off
Designation: Director
Founded: 2007
Status: Active
Designation: Director
Founded: 2008
Status: Strike Off
Designation: Director
Founded: 2005
Status: Converted To Llp
Designation: Director
Founded: 2006
Status: Strike Off
Designation: Additional Director
Founded: 2002
Status: Converted To Llp
Designation: Director
Founded: 2005
Status: Converted To Llp
Designation: Additional Director
Explore Director's current and past company associations— Uncover their professional journey today!
Milind Arunkumar Antani has 19 years in corporate governance. Holds Nominee Director and Director roles. Currently with 11 companies, including Patheon Pharmaceuticals India Private Limited and Snd Pharma Research & Development Private Limited. Formerly with 12 companies, such as Biogen Idec Biotech India Private Limited and Actelion Pharmaceuticals India Private Limited. Engaged in General Business, Technology and more.
Milind Arunkumar Antani is associated with 11 companies as Nominee Director and Director.
Milind Arunkumar Antani has expertise in General Business, Technology and other sectors.
Milind Arunkumar Antani has 19 years in corporate governance.